Term ends Oct 26, 2037 · Low confidence
20-year base term ends Oct 26, 2037
Held by Janssen Pharmaceutica N.V.
Filed Aug 21, 2020 as application 16/947,875 · Granted Aug 2, 2022
Base term, 20 years from filing
Today
2017
2037
Clock starts
Oct 26, 2017
Oct 26, 2017
Term ends
Oct 26, 2037
Oct 26, 2037
Granted
Aug 2, 2022
Aug 2, 2022
base term
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,640,544, US 10,968,265, to Oct 26, 2037. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 26, 2017, when application 15/794,250, the earliest non-provisional in its chain, was filed (this one was filed Aug 21, 2020); a parent in its chain could not be resolved (the next row) | Oct 26, 2037 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,640,544, US 10,968,265) | resolves to Oct 26, 2037, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 16542751, 15794250 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Oct 26, 2037 | Low confidence |
This family
| US 10,428,134 | In force no later than Oct 2037 | no later than Oct 2037 |
| US 10,787,495 | In force Oct 2037 | Oct 2037 |
| US 11,401,315 | this patent Oct 2037 | Oct 2037 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 21, 2020 Reel 53571, frame 886 | Macielag, Mark; Patch, Raymond J.; Zhang, Rui; Case, Martin A.; Rangwala, Shamina M.; Leonard, James N.; Camacho, Raul C.; Hunter, Michael J.; D'aquino, Katharine E.; Edwards, Wilson; Swanson, Ronald V.; Jian, Wenying; Zhang, Yue-mei; Wall, Mark J.; Chi, Ellen | Janssen Pharmaceutica N.V. | Assignment of Assignor's Interest |
| Jun 6, 2024 Reel 67641, frame 497 | Centocor Research & Development, Inc.; Janssen Research & Development, LLC | Janssen Pharmaceutica N.V. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2037
Term ends Oct 26, 2037. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,640,544, US 10,968,265, ends no earlier than this term, so it caps nothing.
Citations
1
later US patent cites this one
That is below the median of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.